Carmila: Filing of the 2023 Universal Registration Document
15 Marzo 2024 - 10:45AM
Business Wire
Regulatory News:
Carmila (Paris:CARM) filed its 2023 Universal Registration
Document with the French Financial Markets Authority (AMF) on 15
March 2024 under number D.24-0118.
This document is available on the Company’s website
www.carmila.com and will be made available at its registered Head
Office.
INVESTOR AGENDA
17 April 2024 (after market close): Financial information
for the first quarter 2024 24 April 2024: Annual Shareholder
Meeting 24 July 2024 (after market close): First half 2024
results 25 July 2024: First half 2024 results presentation
17 October 2024 (after market close): Financial information
for the third quarter 2024
ABOUT CARMILA
As the third-largest listed owner of commercial property in
Europe, Carmila was founded by Carrefour and large institutional
investors in order to enhance the value of shopping centres
adjoining Carrefour hypermarkets in France, Spain and Italy. At 31
December 2023, its portfolio was valued at €5.9 billion and is made
up of 201 shopping centres, with leading positions in their
catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”). Carmila has been a member of the SBF
120 since 20 June 2022.
Important notice
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
This press release is available in the
“Regulatory Information” section of Carmila’s Finance
webpage:https://www.carmila.com/en/finance/regulatory-information/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240315916392/en/
INVESTOR AND ANALYST CONTACT Jonathan Kirk – Head of Investor
Relations jonathan_kirk@carmila.com +33 6 31 71 83 98
PRESS CONTACT Elodie Arcayna – Corporate Communications Director
elodie_arcayna@carmila.com +33 7 86 54 40 10
Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De May 2023 a May 2024